Organizers: E. Cattaneo and A. Smith
University of Milano and Eurostemcell Consortium
April 6-7, 2005
Place of the Conference: Universita’ degli Studi di Milano, Aula Magna – Via Festa del Perdono 7, Milano, Italy
April 6th, 2005
Opening Ceremony
09:00 Rodolfo Paoletti, Dean of the Faculty of Pharmacy
E.Cattaneo and A. Smith, Welcome address on behalf of the
Eurostemcell Consortium
Presentation by Patients Associations
09:15-09:30 Filippo Buccella, President of the Duchenne Parent Project
09:30-09:45 Luca Coscioni, President of the Luca Coscioni Association
Plenary Lecture
09:45-10:30 Daniel Pipeleers, Diabetes Research Center, Belgium
Beta cells therapy for diabete
10:30 Coffee Break
1) The potential of stem cell research
chaired by Anders Bjorklund (Sweden)
11:00-11:30 Austin Smith, Coordinator of EuroStemCell, University of Edinburgh, Edinburgh, UK
Embryonic stem cells and tissue stem cells
11:30-12:00 Yann Barrandon, Swiss Federal Institute of Technology, Lausanne, Switzerland
Functional analysis of skin renewal
12:00-12:30 Olle Lindvall, Lund University, Lund, Sweden
Stem cell therapy for human brain disease–will it ever work?
12:30 Lunch Buffet
2) Session on “Ethical Aspects of stem cell research”
chaired by Goran Hermeren, (Sweden)
14:00-14:30 Goran Hermeren, Lund University, Sweden
Ethical aspects of stem cell research
14:30-15:00 Demetrio Neri, University of Messina, Italy Stem cell research: the Italian debate and legislation
15:00-15:30 Mauro Capocci, University of Rome, Italy
Regeneration: from myth to stem cells
15:30-16:00 Giuseppe Testa, Max Planck Institute, Dresden, Germany Ethical and legal dimensions of genome reprogramming
16:00 Coffee Break
3) Application of stem cell research to neurodegenerative diseases
chaired by Lorenzo Magrassi (Italy)
16:30-17:00 Anders Bjorklund, Lund University, Lund, Sweden
Stem Cell Therapy for Parkinson´s disease
17:00-17:30 Oliver Brustle, University of Bonn, Bonn, Germany
Generation and Transplantation of Functional ES Cell-Derived Neurons and Glia
April 7th, 2005
Plenary Lecture
09:00-09:45 Ronald D.G. McKay, NIH, Bethesda, USA
The molecular biology of stem cells
4) Application of stem cell research to neurodegenerative diseases
chaired by Ferdinando Rossi (Italy)
09:45-10:15 Elena Cattaneo, University of Milano, Milano, Italy
Novel neural stem cell systems for gene function studies
10:15-10:45 Ernest Arenas, Karolinska Institute, Stockholm, Sweden
Regulation of dopaminergic neurogenesis by glial-derived signals and Wnt
10:45 Coffee Break
5) Stem Cell Biotechnology: producing characterised resources for research& development chaired by Tim Allsopp (Edinburgh)
11:15-11:35 John McCafferty, Sanger Institute, Cambridge, United Kingdom Antibodies for stem cell identification
11:35-11:55 Tim Allsopp, Stem Cell Sciences Ltd, Edinburgh
Producing ES cells at scale
11:55-12:15 Lars Wahlberg, Ns Gene A/S, Ballerup, Denmark
Human neural progenitor cell lines for cell therapy
12:15-12:35 Anders Haegerstrand, NeuroNova AB, Stockholm, Sweden
Discovery of neural stem cell growth stimulating mechanisms: from mice to men,
12:35-12:55 Pasquale De Blasio, BioRep Inc., Milano, Italy
Establishing a European stem cell repository
12:55 Lunch Buffet
6) Isolation and potentialities of stem cells from the hematopoietic system
chaired by Daniel Pipeleers (Belgium)
14:00-14:30 Tariq Enver, The Institute of Cancer Research, London, UK
Transcriptional programming in normal and leukaemic stem and progenitor cells
14:30-15:00 Claus Nerlov, EMBL, Monterotondo, Italy
Regulation of haematopoietic progenitor proliferation and differentiation: The interaction between cell cycle regulators and lineage-specific gene expression programs
15:00-15:30 Ana Cumano, Institut Pasteur, Paris, France
Hematopoietc cell generation in the mouse embryo
7) Myogenic stem cells
chaired by Yvan Torrente (Italy)
15:30-16:00 Margaret Buckingham, Institut Pasteur, France
Pax genes control muscle stem cell fate
16:00-16:30 Shahragim Tajbakhsh, Institut Pasteur, Paris, France
Establishing skeletal muscle from stem cells: patchworks and networks
16:30-17:00 Giulio Cossu, S. Raffaele Hospital, Milano, Italy
Mesoangioblasts for the cell therapy of primary myopathies
17:00 Closure -Wine and cheese
